PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY
Clinical trials for PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a blood vessel drug ease chemo nerve damage?
Symptom relief Not yet recruitingThis study tests whether papaverine, a drug that relaxes blood vessels, can relieve nerve pain and numbness caused by taxane chemotherapy. It includes 43 adults whose symptoms have not improved with standard treatments. Participants receive papaverine infusions once a week for up…
Matched conditions: PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 26, 2026 08:59 UTC
-
Simple glove trick may shield breast cancer patients from chemo nerve pain
Symptom relief Not yet recruitingThis study tests a simple, low-cost method—wearing surgical gloves during chemotherapy—to prevent nerve damage in the hands caused by the drug paclitaxel. About 84 breast cancer patients will be randomly assigned to either standard care or glove compression. Researchers will trac…
Matched conditions: PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Necmettin Erbakan University • Aim: Symptom relief
Last updated May 26, 2026 08:32 UTC
-
Oxygen therapy tested to soothe chemo nerve pain
Symptom relief Not yet recruitingThis study looks at whether hyperbaric oxygen therapy can reduce nerve pain and numbness caused by a common chemotherapy drug (nab-paclitaxel) in breast cancer patients. About 160 women who have finished chemo and developed nerve symptoms will receive either oxygen therapy or sta…
Matched conditions: PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC